AsiaTechDaily – Asia's Leading Tech and Startup Media Platform
AsiaTechDaily is thrilled to announce Dr. Poh Hui Chia as our Investor of the Month. Dr. Chia, an Associate Director of Vickers Venture Partners, is an eminent leader in the venture capital space, mainly known for her impactful contributions in the biotech and healthcare sectors.
Since joining Vickers Venture Partners in 2018, Dr. Chia has been instrumental in establishing the firm’s Silicon Valley office and has played a key role in sourcing and evaluating investment opportunities. Her scientific background and keen investment acumen have enabled her to identify promising ventures and provide invaluable insights to portfolio companies.
Dr. Chia serves as a director on the board of Emergex, a company specializing in synthetic T-cell vaccine technology, and holds observer roles on the boards of Aardvark (focused on obesity drug development), Sisaf (RNA therapeutics), AWAK (next-generation kidney dialysis devices), and Biosplice (RNA-splicing modulatory therapeutics). Additionally, she operates as Executive Director (Asia) at Biosplice.
Before her tenure at Vickers, Dr. Chia was a scientist at the Institute of Medical Biology (IMB), a division of the Agency for Science Technology and Research (A*STAR) in Singapore, where her research focused on inherited genetic diseases. Her academic credentials include a B.S. in Biochemistry from the University of Wisconsin-Madison and a Ph.D. in Neuroscience from Stanford University. Her work on brain development and genetic diseases has been recognized in prestigious scientific journals such as Nature and Cell.
Dr. Chia embodies the qualities that AsiaTechDaily looks for in an Investor of the Month. Her extensive experience in early-stage investments, particularly in the biotech and healthcare sectors, combined with her scientific expertise, makes her a visionary and a leader to guide startups. Her contributions to the field and her role in advancing innovative healthcare solutions align perfectly with our mission to highlight leaders who drive positive change and support innovation.
In line with this announcement, AsiaTechDaily is excited to share that we will be hosting an exclusive online event featuring Dr. Chia. This event will focus on navigating early-stage investments, funding and scaling biotech ventures and exploring global perspectives on biotech investments. It’s an unmissable opportunity for health tech and biotech startups to gain insights from one of the industry’s foremost experts. Stay tuned for more details!
As a pioneering deep-tech venture capital firm in Asia, Vickers Venture Partners is dedicated to creating long-term value for its investors through strategic investments in a portfolio of companies with substantial growth potential. Vickers takes pride in curating a diverse portfolio of forward-thinking enterprises aiming to transform the world positively. With a team of domain experts spanning multiple fields of deep tech and finance, Vickers is well-equipped to identify and nurture breakthrough innovations with the potential to redefine industries and create lasting global impact.
Headquartered in Singapore, Vickers Venture Partners maintains a strong global presence with offices in key innovation hubs such as New York, Silicon Valley, Europe, and Shanghai. This extensive network ensures that Vickers remains at the forefront of emerging trends and investment opportunities, solidifying its position as a leader in the venture capital landscape.
Stay connected with AsiaTechDaily for further updates on the event and to learn more about Dr. Poh Hui Chia’s remarkable contributions to the biotech and healthcare sectors.
Also Read: